Amphastar Pharmaceuticals, Inc. Quarterly Return On Equity in % from Q1 2018 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Amphastar Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2018 to Q2 2024.
  • Amphastar Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2024 was 25.4 %, a 35.4% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. annual Return On Equity for 2023 was 23.2 %, a 27.7% increase from 2022.
  • Amphastar Pharmaceuticals, Inc. annual Return On Equity for 2022 was 18.2 %, a 31.1% increase from 2021.
  • Amphastar Pharmaceuticals, Inc. annual Return On Equity for 2021 was 13.9 %, a 4256% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 25.4 +6.64 +35.4% Apr 1, 2024 Jun 30, 2024
Q1 2024 24.8 +6.89 +38.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 23.2 +5.03 +27.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 23.9 +7.92 +49.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 18.8 -0.83 -4.23% Apr 1, 2023 Jun 30, 2023
Q1 2023 17.9 +0.05 +0.28% Jan 1, 2023 Mar 31, 2023
Q4 2022 18.2 +4.31 +31.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 16 +7.98 +99.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 19.6 +17.3 +753% Apr 1, 2022 Jun 30, 2022
Q1 2022 17.9 +17.3 +3106% Jan 1, 2022 Mar 31, 2022
Q4 2021 13.9 +13.5 +4256% Oct 1, 2021 Dec 31, 2021
Q3 2021 8.03 +6.51 +427% Jul 1, 2021 Sep 30, 2021
Q2 2021 2.3 +1.36 +145% Apr 1, 2021 Jun 30, 2021
Q1 2021 0.56 -11.6 -95.4% Jan 1, 2021 Mar 31, 2021
Q4 2020 0.32 -11.4 -97.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 1.52 -11.4 -88.2% Jul 1, 2020 Sep 30, 2020
Q2 2020 0.94 -13 -93.3% Apr 1, 2020 Jun 30, 2020
Q1 2020 12.1 +11.5 +1771% Jan 1, 2020 Mar 31, 2020
Q4 2019 11.7 +13.4 Oct 1, 2019 Dec 31, 2019
Q3 2019 12.9 +14.7 Jul 1, 2019 Sep 30, 2019
Q2 2019 13.9 +16.5 Apr 1, 2019 Jun 30, 2019
Q1 2019 0.65 +1.74 Jan 1, 2019 Mar 31, 2019
Q4 2018 -1.7 Oct 1, 2018 Dec 31, 2018
Q3 2018 -1.87 Jul 1, 2018 Sep 30, 2018
Q2 2018 -2.59 Apr 1, 2018 Jun 30, 2018
Q1 2018 -1.1 Jan 1, 2018 Mar 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.